Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics.
B Vora, DJ Brackman, L Zou… - Clinical and …, 2021 - escholarship.org
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
B Vora, DJ Brackman, L Zou… - Clinical and …, 2021 - pubmed.ncbi.nlm.nih.gov
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
[PDF][PDF] Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
B Vora, DJ Brackman, L Zou, M Garcia-Cremades… - 2021 - scholar.archive.org
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
B Vora, DJ Brackman, L Zou… - Clinical and …, 2021 - search.proquest.com
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics.
B Vora, DJ Brackman, L Zou… - Clinical and …, 2021 - europepmc.org
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
[HTML][HTML] Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
B Vora, DJ Brackman, L Zou… - Clinical and …, 2021 - ncbi.nlm.nih.gov
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics.
B Vora, DJ Brackman, L Zou… - Clinical and …, 2021 - europepmc.org
The missense variant, breast cancer resistance protein (BCRP) p. Q141K, which encodes a
reduced function BCRP, has been linked to poor response to allopurinol. Using a …
reduced function BCRP, has been linked to poor response to allopurinol. Using a …